Duopharma Biotech may trend higher after it broke out from its 2-month ascending triangle pattern yesterday. The stock posted three white candles in a row and its 20-day EMA started to turn up, likely indicating the return of buying interest. A bullish bias may emerge above the RM1.44 level, and the bullish momentum should lift it towards the subsequent resistance levels of RM1.55, followed by RM1.62. Towards the downside, stop-loss is set at RM1.34, below the 50-day EMA.

Entry : RM1.44-1.47

Target : RM1.55, RM1.62

Exit : RM1.34

Source: AmInvest Research - 30 Nov 2022